Tilray Brands Financial Results
Tilray Brands reported record Q1 fiscal 2027 net revenue of $257.1 million, a 23% increase year-over-year, driven by double-digit growth in international cannabis, beverage, and pharmaceutical distribution. The company expanded its gross margin to 30% and reduced its outstanding debt by $42 million fiscal year-to-date, ending the quarter in a net cash position.
- Term
- Q1 2027
“Tilray’s record first-quarter revenue and gross profit demonstrate the power of the diversified platform we have built and the momentum we are creating across cannabis, beverage, hospitality, wellness and pharmaceutical distribution. We are no longer dependent on a single market or regulatory catalyst. We have multiple engines of growth, a scaled international footprint and the ability to convert scale into stronger margins, greater efficiency and sustainable, profitable growth.”
Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands
“Our global platform is translating into leadership positions across our core categories. In cannabis, Tilray is a leading cannabis producer, with more than 6 million square feet of cultivation capacity across Canada, Portugal and Germany, and a leading low-cost production base in the world’s largest legally regulated markets, supported by one of the largest EU-GMP certified footprints in the world.”
Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands